Corbus Pharmaceuticals Inc.

CRBP | NASDAQ

Price Alert Chart Builder DCF Calculator

$7.65

+$0.17 (+2.27%)

At close: Sep 21, 2026, 4:00 PM ET

$7.40

-$0.25 (-3.27%)

Pre-market: Sep 22, 2026, 6:10 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $141.74M

Enterprise Value $122.63M

Beta 2.64

Average Volume 490.72K

Shares Outstanding (Diluted) 19.41M

Shares Change YoY 58.56%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US21833P3010

Price Performance

Price Change 1M -23.6%

Price Change 3M -9.6%

Price Change 6M -7.9%

Price Change YTD -2.8%

Price Change 1Y -33.8%

Price Change 3Y 12.5%

Price Change 5Y -75.5%

1M CAGR (ann.) -24.8%

1Y CAGR (ann.) -34.2%

5Y CAGR (ann.) -26.0%

All-Time CAGR -18.7%

Valuation

PE Ratio -1.10

Forward PE N/A

PEG Ratio 0.04

Forward PEG -0.81

PS Ratio N/A

Forward PS 39.40

PB Ratio 1.39

P/FCF Ratio -1.26

P/Adj. FCF Ratio -1.17

P/OCF Ratio -1.71

EV/Sales N/A

EV/EBIT -1.83

EV/EBITDA -1.84

EV/FCF -1.09

Earnings Yield -91.1%

FCF Yield -79.2%

Adj. FCF Yield -85.3%

Financial Health

Net Cash $19.11M

Total Debt $4.26M

Cash & Short-Term Investments $23.37M

Total Assets $126.99M

Current Ratio 5.71

Quick Ratio 5.71

Debt / Equity Ratio 0.04

Debt / EBITDA -0.06

Debt / FCF -0.04

OCF / Debt -26.32

Interest Coverage 0.00

Altman Z-Score -4.11

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -7.7%

Returns

Return on Assets -80.3%

Return on Equity -87.0%

Return on Invested Capital -100.3%

Return on Capital Employed -101.3%

Return on Tangible Assets -80.3%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y -100.0%

Revenue CAGR 10Y -28.4%

EPS CAGR 3Y 21.4%

EPS CAGR 5Y 11.1%

EPS CAGR 10Y 14.7%

FCF CAGR 3Y -61.5%

FCF CAGR 5Y -33.6%

FCF CAGR 10Y -9.4%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 16

EPS Growth Next 3Y 14.6%

Revenue Growth Next 3Y N/A

Earnings Date Nov 10, 2026

EPS Estimate (next Q) -$1.21

EPS Growth Est (next Q) -36.1%

Revenue Est (next Q) $1.67M

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $33.67

Price Target Upside 340.1%

Cash Flow

Operating Cash Flow $-112.24M

Free Cash Flow $-112.26M

Adj. Free Cash Flow $-120.91M

FCF Per Share -$4.47

OCF Per Share -$4.47

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-49K

Operating Income $-70.69M

EBITDA $-66.72M

Net Income $-101.9M

EPS (Diluted) -$6.97

Revenue / Employee N/A

Profit / Employee $-2.83M

Employees 36